卡维地洛对兔扩张型心肌病心肌细胞电重构的影响

贺莉; 李论; 肖杰; 高波; 肖建民; 顾晔

doi:10.13201/j.issn.1001-1439.2014.07.020

卡维地洛对兔扩张型心肌病心肌细胞电重构的影响

- 1 武汉市普爱医院心内科 (武汉, 430033);
- 2 广东省东莞太平医院心内科
基金项目:
国家自然科学基金资助项目 (No:30971180)

详细信息

通讯作者: 顾晔,E-mail:yegu2003@yahoo.com.cn

中图分类号: R541.6

收稿日期: 2014-01-07

Effect of carvedilol on electrical remodeling in rabbit with ADR cardiomyopathy

- 1 Department of Cardiology, Puai Hospital, Wuhan, 430033, China;
- 2 Department of Cardiology, Taiping Hospital in Dongguan of Guangdong Province

More Information

Corresponding author: GU Ye, E-mail: yegu2003@yahoo.com.cn

Received Date: 07 January 2014

摘要

摘要: 目的:研究卡维地洛对阿霉素心肌病兔心肌细胞晚期后除极 (DADs) 和触发活动 (TA) 发生率的影响, 并探讨氧化应激与心肌病电重构之间的关系。方法:40只新西兰大白兔随机分为对照组、阿霉素组、阿霉素+卡维地洛组 (卡维地洛组) 和阿霉素+倍他乐克组 (倍他乐克组), 每组10只。建立阿霉素扩张型心肌病模型 (阿霉素1mg·kg-1, iv每周两次, 共16次)。3周后, 对照组和阿霉素组每日以0.9%氯化钠 (5ml·kg-1·d-1) 灌胃, 卡维地洛组和倍他乐克组分别给予卡维地洛 (5mg·kg-1·d-1) 和倍他乐克 (5mg·kg-1·d-1) 灌胃, 两个月。超声心动图观察各组心脏结构变化, 检测血浆中丙二醛 (MDA)、谷胱甘肽过氧化酶 (GSH-Px) 和超氧化物歧化酶 (SOD) 的浓度, 酶解法分离家兔心室肌细胞, 应用全细胞膜片钳技术记录动作电位 (AP), 观察在快频率电刺激下DADs和TA的发生率。结果:与对照组比较, 阿霉素组左室舒张末期容积 (LVEDV) 增大, SOD和GSH-Px降低, MDA增高, 左室射血分数 (LVEF) 降低;与阿霉素组和倍他乐克组比较, 卡维地洛组LVEDV缩小, MDA降低, SOD和GSH-Px增加, LVEF增加 (均P＜0.05);3Hz刺激下, 对照组未诱发出DADs和TA, 阿霉素组DADs和TA的诱发率显著增加, 分别为18/20和11/20 (P＜0.05);卡维地洛组和倍他乐克组DADs的发生率分别为10/20、16/20, TA的发生率分别为4/20、10/20, 两组比较有统计学差异 (P＜0.05)。结论:阿霉素心肌病兔心肌氧化应激水平增加, 心肌细胞电重构, DADs和TA发生率明显增加;卡维地洛降低氧化应激水平, 改善心肌细胞电重构, 从而降低了DADs和TA的发生。
- 心力衰竭 /
- 卡维地洛 /
- 触发活动 /
- 晚期后除极
Abstract: Objective: To investigate the effect of carvedilol on triggered activity (TA) and delayed afterdepolarizations (DADs) in cardiac myocytes of rabbits with adriamycin cardiomyopath and the relation between oxidative stress and electrical remodeling in adriamycin cardiomyopath.Method: Forty New Zealand white rabbits were randomly divided into four groups (n=10each):the control group, the adriamycin group, the carvedilol group and the metoprolol group.Rabbits in the adriamycin group, the metoprolol group and the carvedilol group were intravenously injected at auri-edge with adriamycin hydrochloride (1mg·kg^-1) twice a week for 8 weeks, and at the same timepoint those in the control group were injected with equal saline.Thereafter, rabbits in the metoprolol group and the carvedilol group were intragastric administrated with metoprolol and carvedilol (5mg·kg^-1·d^-1) respectively, and those in the control group and the adriamycin group were intragastric administrated with equal volume of saline.Two months later, left ventricular end diastolic volume (LVEDV), left ventricular end systolic volume (LVESV) and left ventricular shortening fraction (LVFS) were measured by echocardiogram;MDA, SOD and GSH-Px were mearured.By enzymatic dissociation method, single ventricular myocytes were isolated.Then by whole cell patch clamp technique, action potentials (APs) were recorded.The incidences of delayed afterdepolarizations (DADs) and triggered activity (TA) were monitored under fast frequency electrical stimulation.Result: Adriamycin increased MDA, LVEDV and LVESV, and decreased SOD and GSH-Px.And the incidences of DAD sand TA (18/20, 11/20) were significant higher than those in the control group (0/20, 0/20) (P＜0.05).Carvedilol increased SOD and GSH-Px, decreased MDA, LVEDV and LVESV, and inhibited the increase of incidences of DADs and TA (10/20, 4/20) (P＜0.05).There were no significant different in LVESV, LVEDV and the incidences of DADs and TA between the metoprolol group and the adriamycin group.Conclusion: Carvedilol can inhibit the occurrence of DADs and TA in rabbits with adriamycin cardiomyopathy and protect adriamycin-induced cardiotoxicity, which relate to oxygen free radial production.
- heart fairlure /
- carvedilol /
- trigger action /
- delayed afterdepolarizations

HTML全文

参考文献(11)

[1]	唐健秀, 彭志刚.蒽环类药物心脏毒性的研究进展[J].内科杂志, 2008, 3 (5):746-747.
[2]	CHATTERJEE K, ZHANG J, HONBO N, et al.Doxorubicin cardiomyopathy[J].Cardiology, 2010, 115:155-162.
[3]	杨辉, 吴伟康.阿霉素性心力衰竭模型与氧化应激[J].医学动物防制, 2004, 20:655-657.
[4]	DUAN D D.A leakage leads to failure:roles of sarcoplasmic reticulum Ca²⁺ Leak via RyR2 in heart failure progression[J].Hypertension, 2010, 55:849-851.
[5]	陈国雄, 卜军, 张存泰, 等.β受体阻滞剂对动脉粥样硬化兔体内氧化应激的影响[J].临床心血管病杂志, 2007, 23 (12):935-938.
[6]	蔡少艾, 刘念, 张存泰, 等.钙调蛋白激酶II信号转导路径在儿茶酚胺敏感性室性心动过速中的作用[J].中国心脏起搏与心电生理杂志, 2009, 23 (4):334-336.
[7]	柯俊, 张存泰, 马业新, 等.钙调蛋白激酶Ⅱ抑制剂对肥厚心肌细胞早期后除极的影响[J].内科急危重症杂志, 2007, 13 (6):292-295.
[8]	贺莉, 肖建民, 付晖, 等.卡维地洛对阿霉素心肌病兔氧化应激的影响[J].临床心血管病杂志, 2012.28 (2):107-109.
[9]	白永虹, 沈兴, 余更生, 等.兔阿霉素心衰模型的建立[J].重庆医科大学学报, 2006, 31 (6):818-820.
[10]	DMITRY T, INNA GYÖRKE, ANDRIY E, et al.Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca²⁺ leak in chronic heart failure[J].Circ Res, 2008, 103:1466-1472.
[11]	CHAISWING L, COLE M P, ST CLAIR D K, et al.Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury[J].Toxicol Pathol, 2004, 32:536-547.